CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
This project focuses on developing a blood test to identify a specific type of immune cell, known as immunotherapy-responsiveness cells, which can predict patient response to immune checkpoint inhibitors in cancer treatment. By utilizing flow cytometry, the goal is to enhance personalized immunotherapy and support phar…
Immunotherapy has revolutionised clinical oncology, with the use of immune checkpoint inhibitors (ICIs).
These agents are in clinical use for almost a decade, treating over 20 types of cancers.
They have shown a remarkable therapeutic benefit even in patients with advanced disease.
Yet, only a small proportion of patients benefit from this therapy, leaving the rest resistant, for reasons that are still not clear.
While there are certain clinical biomarkers to predict ICI therapy outcome, their p…
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
